Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL)

Name: Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List (PDL). Note that both the human and veterinary parts of the PDL were revised with the addition of a qualifier.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-10-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) (English, HTML) HTML
Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) (French, HTML) HTML

Related open data

Health Canada